To find out whether disease activity and B27 status were associated with serum concentrations of IgA, C reactive protein (CRP), and haptoglobin in ankylosing spondylitis (AS) multivariate analysis of variance was used to study 101 patients with AS whose disease was clinicaily classified as active or inactive, and who were HLA-B27 typed. It was found that B27 and disease activity do interact significantly to affect the serum concentrations of IgA, CRP, and haptoglobin. When the 77 B27+ patients were examined, however, it was found that disease activity was significantly associated with serum concentrations of CRP and haptoglobin, but not with serum IgA. In contrast, in the 24 B27-patients concentrations of serum IgA were significantly associated with disease activity, but concentrations of CRP and haptoglobin were not. These results emphasise the known difference between B27+ and B27-AS and suggest different pathogenic mechanisms in the two forms of AS.
Ankylosing spondylitis (AS) shows a remarkable association with HLA-B27, and mounting evidence suggests that the B27 gene may have a pathogenic role in the development of AS.` '3 Several investigators have also noted that serum concentrations of IgA and certain serum markers of inflammation, such as C reactive protein (CRP) and haptoglobin, are raised in patients with AS.'
We performed this study to investigate pathophysiological differences between B27+ and B27-patients with AS and relate these differences to the serum concentrations of IgA, CRP, and haptoglobin to determine whether the B27 status and presence or absence of disease activity could predict the concentrations of IgA, CRP, and haptoglobin.
Patients and methods

PATIENTS
We studied 303 unrelated white Swiss patients with definite AS as defined by the To understand better the nature of this interaction the 77 B27+ patients were analysed using disease activity as the sole independent variable. We then performed MANOVA and looked at the individual univariate F statistics to see whether each protein was affected equally by disease activity. In these B27+ patients disease activity was significantly associated with both serum CRP (p<0-017, univariate F statistic=5-93, n=77) and serum haptoglobin (p<0014, univariate F statistic=6'32, n=77), but was not significantly associated with serum IgA concentrations.
In contrast, when the 24 B27-patients were studied and disease activity was established as an independent variable only concentrations of serum IgA were significantly associated with disease activity status (p<0-008, univariate F statistic=8 60, n=24); neither serum CRP nor serum haptoglobin were significantly associated with disease activity in B27-patients.
Discussion
Research into the pathophysiological mechanisms of AS is problematic because of the presumed heterogeneous nature of the disease. ' This work emphasises the fact that as investigators have been able to study more B27-patients they have been able to show clinical differences between B27+ and B27-AS. Several, epidemiological differences have been described between B27+ and B27-patients with AS: B27+ patients have a slightly earlier age of onset, often show familial aggregation, and develop acute anterior uveitis significantly more commonly than B27-patients.21224 Now we have provided a demonstration of serological differences as well. This research further strengthens the possibility that AS represents a heterogeneous group of diseases and that the pathogenic mechanism in B27+ disease may differ from that in B27-AS. Our data thus add to the growing body of evidence supporting the clinical and genetic heterogeneity of AS.
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